Yomiuri flags U.S. drug pricing policy risks for Japan supply
Yomiuri reports a U.S. drug pricing policy linked to President Donald Trump is raising fears Japan’s “drug-loss” problem could worsen, with medicines used overseas becoming unavailable domestically.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.